Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2rhpn6xPhase 3Recruiting
Phase 3, randomised, single-blind trial of morphine, ropivacaine, dexamethasone and epinephrine in ankle fracture (3 arms), sponsored by Hospital Getúlio Vargas. Primary endpoint: Postoperative pain intensity at 24 hours. Started Jul 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2rhpn6x.